Key result
RyR1 mutations require a Ca2+/ROS-activated IL-6 autocrine loop to alter myonuclear density in congenital myopathies.
Key points are not available for this paper at this time.
Overactive RyR1 mutant proteins are associated with muscle disease; interestingly, they increase the number of myonuclei when expressed in C2C12 cells. We discovered that this alteration depends on a Ca 2+ /ROS loop, which recruits calpain and calcineurin to stimulate the production of IL-6 and the subsequent autocrine activation of p38. Thus, disease-causing RyR1 mutations require an IL-6 autocrine system to alter myonuclear density. This novel mechanism could be critical to understanding the pathogenesis of congenital myopathies.
No takes yet. Share an insight, caveat, or question.
Valle-Clara et al. (2025) studied this question. Disease-causing RyR1 mutations require an IL-6 autocrine system, activated via a Ca2+/ROS signaling loop, to alter myonuclear density in congenital myopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: